“Honey, We Shrunk the Curve!”
By Jonathan Carson, PhD and Jon A. Rowley, PhD, with acknowledgement to scientists who sounded the alarm like Dr. Liz Specht and to all health workers on the front lines. ... More
Mesenchymal Stem / Stromal Cells
Can MSCs Treat Patients with COVID-19?
Authored by Mayasari Lim | West Coast and APAC lead for RoosterBio Amidst the scramble and panic-buying that some of us are experiencing, several treatments to combat this novel ... More
Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19
Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More
What Are MSCs?
Originally Authored by Jon A. Rowley, PhD, Founder (February 15, 2014). Updated by Iain Farrance, PhD and Jon Carson, PhD (February 5, 2020) What’s in a Name? MSC is the common ... More
Quality Begins at Inception
Authored by: Kathy Williams, Vice President of Quality Assurance/Regulatory Affairs and Caitlin Hansen, Director of Quality Control RoosterBio Quality Excellence: we nurture a hard-working innovative culture where quality begins at ... More
MSC-EVs Emerge as Clinical Therapies
Authored by: Katrina Adlerz, PhD, Scientist, RoosterBio and Divya Patel, PhD, Scientist, RoosterBio MSC-EVs Emerge as a Cell-Free Therapy Extracellular vesicle (EV) interest continues to increase as more evidence emerges ... More
Best Practices in MSC Culture: Tracking and Reporting Cellular Age Using Population Doubling Level (PDL) and not Passage Number
Originally Published: July 7, 2014 Updated October 2019 by: Taby Ahsan, Ph.D., Vice President of Analytical, Process & Product Development & Katrina Adlerz, Ph.D., Scientist, Development What is Population Doubling Level ... More
RoosterBio Products Continue to Expand Presence in Major Mesenchymal Stem/Stromal Cell (MSC)-related Regenerative Medicine Peer Reviewed Publications
Authored by Joseph Candiello, Ph.D., Technical Application Specialist Human Mesenchymal Stem/Stromal Cells (hMSCs) are a critical starting material in a growing variety of established and emerging applications spanning the Regenerative ... More
Cryopreserved hMSCs maintain comparable in vitro functional activity compared to fresh hMSCs
INTRODUCTION: Human mesenchymal stem cells (hMSC) are currently in use in over 400 clinical trials and are critical components of tomorrow’s cell-based products and devices (1, 2, 3). The secretion ... More
Priming of hMSCs to Improve Potency
By Iain Farrance, Priya Baraniak, and Jon Rowley. RoosterBio. In this blog, we will present internal data and information on priming RoosterBio’s bone marrow-derived human MSCs (hMSC) with pro-inflammatory molecules ... More